The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum.
about
Randomized, controlled, single-masked, clinical study to compare and evaluate the efficacy of microspheres and gel in periodontal pocket therapy.Controlled and targeted drug delivery strategies towards intraperiodontal pocket diseases.Novel antibacterial nanofibrous PLLA scaffolds.Rationale for use of antibiotics in periodontics.Nd:YAG laser irradiation of the tooth root surface inhibits demineralization and root surface softening caused by minocycline application.Periodontitis as an infectious disease: specific features and their implications.In vitro and in vivo investigation of drug-eluting implants for the treatment of periodontal disease.Chemotherapeutics: antibiotics and other antimicrobials.The evaluation of doxycycline controlled release gel versus doxycycline controlled release implant in the management of periodontitis.Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicineAntibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilmThe effect of locally delivered doxycycline as an adjunctive therapy to scaling and root planing in smokers.Synthesis and antibacterial activity of doxycycline neoglycosides.Therapeutic Efficacy of Subgingivally Delivered Doxycycline Hyclate as an Adjunct to Non-surgical Treatment of Chronic Periodontitis.Nanotechnology in ligature-induced periodontitis: protective effect of a doxycycline gel with nanoparticulesLong-term efficacy of subantimicrobial-dose doxycycline as an adjunctive treatment to scaling and root planing: a systematic review and meta-analysis.Intraperiodontal pocket: An ideal route for local antimicrobial drug delivery.The use of locally delivered doxycycline in the treatment of periodontitis. Clinical results.A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.In vitro activity of taurolidine gel on bacteria associated with periodontitis.Doxycycline poly e-caprolactone nanofibers in patients with chronic periodontitis - a clinical evaluation.The effect of doxycycline hyclate, chlorhexidine gluconate, and minocycline hydrochloride on osteoblastic proliferation and differentiation in vitro.A comparative evaluation of atrigel delivery system (10% doxycycline hyclate) Atridox with scaling and root planing and combination therapy in treatment of periodontitis: A clinical studyAn in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics.Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study.Locally delivered doxycycline improves the healing following non-surgical periodontal therapy in smokers.Inflammatory response to chlorhexidine, minocycline HCl and doxycycline HCl in an in vivo mouse model.A novel approach to the use of doxycycline-loaded biodegradable membrane and EDTA root surface etching in chronic periodontitis: a randomized clinical trial.Macroporous acrylamide phantoms improve prediction of in vivo performance of in situ forming implants.Doxycycline-loaded β-tricalcium phosphate release following EDTA root surface etching improved the clinical outcomes in chronic periodontitis: an in vivo study.Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis.The effects of subgingival calculus on the clinical outcomes of locally-delivered controlled-release doxycycline compared to scaling and root planing.Application of bioelectric effect to reduce the antibiotic resistance of subgingival plaque biofilm: An in vitro study.
P2860
Q33648457-DC072A13-E685-4B1F-9470-8AC422B5E0C5Q33894619-366191D6-E20E-4324-B5B4-AAD90CF1CB93Q34107698-22AE3E26-6510-4D58-945C-F9FCF467D2CFQ34989249-08799A31-5252-4AD2-8126-F4790ECE675CQ35039256-6A8047F6-5C20-4FA5-A6E5-4B892698EE7DQ35219134-A64AD5BD-A119-44B1-BF72-8047332D1DA5Q35577261-73F6E14D-8C9D-44EF-8755-EBCA8E2C21A8Q35872108-9A5B8557-A38A-4AD2-AEDC-47F310E23A03Q36283468-165BCC7E-BAEF-4BD4-8965-05BD805E1F45Q36317523-6B7F270F-FEAD-4CF0-8334-8BB6F18C4A7BQ36832159-4C022793-23B8-42B3-97CC-9B64EBFBE2E0Q37045040-F754B3BE-C4A5-43B5-8A0C-DD25756927F8Q37270510-C4C015E8-D5C4-41F5-BAB0-F4F81D8EF970Q37454693-38FDFD02-1FF4-4268-A72C-CF70A4EE3012Q37698223-41DA2BCE-4AD3-489A-A020-26AEDE804293Q37854591-271FF85B-FBCF-4F56-99CE-DA976F4A1240Q37999364-05E71862-9B54-4020-B563-507D2022FB1EQ38548640-7A0A2F0E-F84B-4E45-914D-9F51F243E0E4Q38582536-C87B67A1-926D-40DF-BA2D-FBFCECC61ED0Q41063572-B0C54DBD-C007-4B47-A991-B76AF02271F7Q41969239-0385EDF2-C974-4A34-A341-A0C39FBD9753Q41996160-B35225F6-9399-4573-AD89-F64D1DB2AC95Q42024855-5254169A-E59F-4A93-A10E-A8A041AD5764Q42914108-AF5447EE-257C-4A00-A877-35CC226B9BBFQ44846121-708848CE-2FE4-41B3-8BB7-E9C8DEB4F551Q44981854-EAEE7E9F-026E-4ADF-8D8A-5634FDB84320Q46465128-5B2785A7-1928-4802-8EB6-6743C0C4A92DQ46520839-B3DC297B-3349-4C37-B5DF-DD34C7835B82Q46607363-E8BAC7F3-6EB9-4614-AFBA-A250DF46DFCBQ46962389-72AC88D1-214C-48B5-A3E3-12BA0BB0157AQ51455175-F8236511-91C9-4BB8-BCEA-40B2333CB84CQ52545568-A6F78B91-363E-4FC1-99FA-5EA106800682Q55239603-139FC5C7-E0E5-4CFD-95E4-161C31EC8D2C
P2860
The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
The pharmacokinetic profile of ...... ular fluid, saliva, and serum.
@en
type
label
The pharmacokinetic profile of ...... ular fluid, saliva, and serum.
@en
prefLabel
The pharmacokinetic profile of ...... ular fluid, saliva, and serum.
@en
P2093
P2860
P1476
The pharmacokinetic profile of ...... ular fluid, saliva, and serum.
@en
P2093
C Q Harrold
L R Johnson
N H Stoller
S Trapnell
P2860
P304
P356
10.1902/JOP.1998.69.10.1085
P407
P577
1998-10-01T00:00:00Z